Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

Osoegawa K, Vayntrub TA, Wenda S, De Santis D, Barsakis K, Ivanova M, Hsu S, Barone J, Holdsworth R, Diviney M, Askar M, Willis A, Railton D, Laflin S, Gendzekhadze K, Oki A, Sacchi N, Mazzocco M, Andreani M, Ameen R, Stavropoulos-Giokas C, Dinou A, Torres M, Dos Santos Francisco R, Serra-Pages C, Goodridge D, Balladares S, Bettinotti MP, Iglehart B, Kashi Z, Martin R, Saw CL, Ragoussis J, Downing J, Navarrete C, Chong W, Saito K, Petrek M, Tokic S, Padros K, Beatriz Rodriguez M, Zakharova V, Shragina O, Marino SR, Brown NK, Shiina T, Suzuki S, Spierings E, Zhang Q, Yin Y, Morris GP, Hernandez A, Ruiz P, Khor SS, Tokunaga K, Geretz A, Thomas R, Yamamoto F, Mallempati KC, Gangavarapu S, Kanga U, Tyagi S, Marsh SGE, Bultitude WP, Liu X, Cao D, Penning M, Hurley CK, Cesbron A, Mueller C, Mytilineos J, Weimer ET, Bengtsson M, Fischer G, Hansen JA, Chang CJ, Mack SJ, Creary LE, Fernandez-Viña MA.

Hum Immunol. 2019 Apr;80(4):228-236. doi: 10.1016/j.humimm.2019.01.009. Epub 2019 Feb 6. Review.

PMID:
30738112
2.

Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis.

Cappelli LC, Dorak MT, Bettinotti MP, Bingham CO 3rd, Shah AA.

Rheumatology (Oxford). 2018 Nov 30. doi: 10.1093/rheumatology/key358. [Epub ahead of print]

PMID:
30508191
3.

Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci: A GeT-RM Collaborative Project.

Bettinotti MP, Ferriola D, Duke JL, Mosbruger TL, Tairis N, Jennings L, Kalman LV, Monos D.

J Mol Diagn. 2018 Sep;20(5):703-715. doi: 10.1016/j.jmoldx.2018.05.009. Epub 2018 Jun 26.

PMID:
29959025
4.

HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities.

Gladstone DE, Bettinotti MP.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):645-650. doi: 10.1182/asheducation-2017.1.645. Review.

5.

Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.

McCurdy SR, Kanakry CG, Tsai HL, Kasamon YL, Showel MM, Bolaños-Meade J, Huff CA, Borrello I, Matsui WH, Brodsky RA, Ambinder RF, Bettinotti MP, Fuchs EJ, Rosner GL, Jones RJ, Luznik L.

Biol Blood Marrow Transplant. 2018 Feb;24(2):343-352. doi: 10.1016/j.bbmt.2017.10.023. Epub 2017 Oct 18.

6.

Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.

McCurdy SR, Kasamon YL, Kanakry CG, Bolaños-Meade J, Tsai HL, Showel MM, Kanakry JA, Symons HJ, Gojo I, Smith BD, Bettinotti MP, Matsui WH, Dezern AE, Huff CA, Borrello I, Pratz KW, Gladstone DE, Swinnen LJ, Brodsky RA, Levis MJ, Ambinder RF, Fuchs EJ, Rosner GL, Jones RJ, Luznik L.

Haematologica. 2017 Feb;102(2):391-400. doi: 10.3324/haematol.2016.144139. Epub 2016 Oct 20.

7.

Clinically relevant interpretation of solid phase assays for HLA antibody.

Bettinotti MP, Zachary AA, Leffell MS.

Curr Opin Organ Transplant. 2016 Aug;21(4):453-8. doi: 10.1097/MOT.0000000000000326. Review.

8.

Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumor.

Wang QJ, Hanada K, Perry-Lalley D, Bettinotti MP, Karpova T, Khong HT, Yang JC.

J Immunother. 2005 Nov-Dec;28(6):551-9.

PMID:
16224272
9.

HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.

Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, Ohayon JM, Bettinotti MP, Martin R.

J Neuroimmunol. 2005 Oct;167(1-2):108-19.

PMID:
16111772
10.

New HLA-A, -B, and -C locus-specific primers for PCR amplification from cDNA: application in clinical immunology.

Bettinotti MP, Hadzikadic L, Ruppe E, Dhillon G, Stroncek DS, Marincola FM.

J Immunol Methods. 2003 Aug;279(1-2):143-8.

PMID:
12969555
11.

Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178.

Bettinotti MP, Panelli MC, Ruppe E, Mocellin S, Phan GQ, White DE, Marincola FM.

Int J Cancer. 2003 Jun 10;105(2):210-6.

12.

The use of bioinformatics to identify the genomic structure of the gene that encodes neutrophil antigen NB1, CD177.

Bettinotti MP, Olsen A, Stroncek D.

Clin Immunol. 2002 Feb;102(2):138-44.

PMID:
11846455
13.

Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.

Hanada K, Perry-Lalley DM, Ohnmacht GA, Bettinotti MP, Yang JC.

Cancer Res. 2001 Jul 15;61(14):5511-6.

14.

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

Panelli MC, Bettinotti MP, Lally K, Ohnmacht GA, Li Y, Robbins P, Riker A, Rosenberg SA, Marincola FM.

J Immunol. 2000 Apr 15;164(8):4382-92.

15.

Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typing.

Bettinotti MP, Norris RD, Hackett JA, Thompson CO, Simonis TB, Stroncek D, Marincola FM.

J Immunother. 2000 Mar-Apr;23(2):282-7.

PMID:
10746555
16.

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14.

17.

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.

Cormier JN, Panelli MC, Hackett JA, Bettinotti MP, Mixon A, Wunderlich J, Parker LL, Restifo NP, Ferrone S, Marincola FM.

Int J Cancer. 1999 Mar 1;80(5):781-90.

18.

Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination.

Lee KH, Panelli MC, Kim CJ, Riker AI, Bettinotti MP, Roden MM, Fetsch P, Abati A, Rosenberg SA, Marincola FM.

J Immunol. 1998 Oct 15;161(8):4183-94.

19.

Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy.

Bettinotti MP, Kim CJ, Lee KH, Roden M, Cormier JN, Panelli M, Parker KK, Marincola FM.

J Immunol. 1998 Jul 15;161(2):877-89.

20.

Comprehensive method for the typing of HLA-A, B, and C alleles by direct sequencing of PCR products obtained from genomic DNA.

Bettinotti MP, Mitsuishi Y, Bibee K, Lau M, Terasaki PI.

J Immunother. 1997 Nov;20(6):425-30.

PMID:
9409447
21.

HLA-A* 1104: a new allele found in a Laotian family.

Bettinotti MP, Mitsuishi Y, Lau M, Silver H, Spence A, Terasaki PI.

Tissue Antigens. 1996 Dec;48(6):717-9. No abstract available.

PMID:
9008318
22.

HLA class I/class II interaction in early onset pauciarticular juvenile chronic arthritis.

Paul C, Haas JP, Schoenwald U, Truckenbrodt H, Bettinotti MP, Bönisch J, Brünnler G, Keller E, Nevinny-Stickel C, Yao Z, et al.

Immunogenetics. 1994;39(1):61-4. No abstract available.

PMID:
8225439
23.

DRB1*1605: a new DR2-DRB1 allele found in a German family.

Bettinotti MP, McNicholas A, Keller E, Andreas A, Scholz S, Albert ED.

Immunogenetics. 1994;39(4):300. No abstract available.

PMID:
8119741
24.

Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population.

Haas JP, Kimura A, Andreas A, Hochberger M, Keller E, Brünnler G, Bettinotti MP, Nevinny-Stickel C, Hildebrandt B, Sierp G, et al.

Hum Immunol. 1994 Jan;39(1):31-40.

PMID:
7910160
25.

DNA typing for HLA-DPB1-alleles in German patients with systemic lupus erythematosus using the polymerase chain reaction and DIG-ddUTP-labelled oligonucleotide probes. Members of SLE Study Group.

Yao Z, Hartung K, Deicher HG, Brünnler G, Bettinotti MP, Keller E, Paul C, Gawron C, Mikschl S, Albert E.

Eur J Immunogenet. 1993 Aug;20(4):259-66.

PMID:
8399121
26.

DR2 haplotypes (DRB1, DQA1, DQB1) associated with systemic lupus erythematosus.

Bettinotti MP, Hartung K, Deicher HR, Keller E, Mikschl S, Albert E.

Immunogenetics. 1993;38(1):74-7. No abstract available.

PMID:
8463000
27.

Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes.

Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED.

Immunogenetics. 1993;37(6):449-54.

PMID:
8436420
28.

HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis.

Paul C, Schoenwald U, Truckenbrodt H, Bettinotti MP, Brünnler G, Keller E, Nevinny-Stickel C, Yao Z, Albert ED.

Immunogenetics. 1993;37(6):442-8.

PMID:
8436419

Supplemental Content

Loading ...
Support Center